Latest BioPharma News and In-Depth Analysis | BioPharma BoardRoom

06 February, 2025 | Thursday

Propanc Biopharma Announces That PRP Suppresses TGF-β Pathway & Tumor Microenvironment in Pancreatic Cancer

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer tre...

March 29, 2023 | Wednesday | News

Sandoz announces agreement to acquire leading antifungal agent Mycamine® from Astellas

Sandoz plans to acquire worldwide product rights for Mycamine® (micafungin sodium) from Astellas Acquiring leading global echinocandin, one of three...

January 24, 2023 | Tuesday | News

Carina Biotech Receives FDA “Safe to Proceed” Letter

Receives greenlight from the FDA for Phase 1/2a clinical trial of CNA3103 On track to commence patient enrollment during the first half 2023 Carina B...

January 24, 2023 | Tuesday | News

1
2
3
4
5
6
7

Partner Content

Driving the Future of Biopharma in 2025: How MoleculeAI is Shaping AI-Driven Drug Discovery
19 December, 2025
Shaping Biopharma Purification: Phenomenex’s Vision for 2025
12 December, 2025
Innovating for Impact: Venkata Indurthi on Aldevron’s Vision for Biomanufacturing in 2025
12 December, 2025
Shaping the Future of Gene Therapy: Kerstin Pohl on Analytical Innovations for 2025
12 December, 2025
Redefining Precision Medicine: Demaris Mills on IDT’s Role in Precision Medicine and Gene Synthesis for 2025
12 December, 2025
Building a Sustainable Future: Cytiva’s 2025 Roadmap for Transforming Biopharma
12 December, 2025
Viracta Therapeutics Initiates Strategic Review and Halts NAVAL-1 Trial to Conserve Resources
27 December, 2025
Big Ideas 2025: The Bold Predictions Redefining Biopharma’s Future
10 December, 2025

BioPharma BreakThrough's

Global Proteomics Breakthrough: UK Biobank and Thermo Fisher to Decode Disease
13 January, 2025
Revvity Secures FDA Clearance for EUROIMMUN’s Groundbreaking Free Testosterone Test
13 January, 2025
World Orphan Drug Alliance Expands Global Reach with New Partners in Canada and Latin America
13 January, 2025
Korean Researchers Pioneer Breakthrough Technique to Transform Fibroblasts into Functional Heart Cells
27 December, 2024
HKBU and Shanghai Sixth People's Hospital Pioneer Breakthrough Treatment for Rare Bone Disease XLH
23 December, 2024
Valneva and Serum Institute of India Partner to Deliver Asia’s First Single-Shot Chikungunya Vaccine
19 December, 2024
Bio-Rad Launches Foresight™ Pro 45 cm Chromatography Columns for Biopharma Applications
08 January, 2025
etherna Immunotherapies and Dropshot Therapeutics Join Forces to Accelerate RNA-Based Therapeutics Development
10 January, 2025

Editor Picks

Agilent Drives Strategic Transformation with Strong FY2024 Results, CEO Padraig McDonnell Leads Restructuring for Market Agility and Growth
26 November, 2024
Merck CEO Belén Garijo Declares Strong Q3 2024 Growth, Reaffirms Path to Profitable 2024 Finish
21 November, 2024
CEO Adam Levy Announces Record-Breaking Q3 Revenue for NEXGEL with 141% Year-Over-Year Growth to $2.94 Million
14 November, 2024
Pfizer Appoints Dr. Chris Boshoff to Lead Global R&D Strategy, Pursuing Breakthroughs in Oncology and Beyond
21 November, 2024
Trump’s Back – And Pharma’s Price Tags Might Be in for a Reality Check
07 November, 2024

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

About Us Media Pack Contact Us Privacy Policy

© 2025 Biopharma Boardroom. All Rights Reserved.